Related Experiment Video
Updated: Sep 10, 2025
07:00
Identification of OTX1 and OTX2 As Two Possible Molecular Markers for Sinonasal Carcinomas and Olfactory Neuroblastomas
Published on: February 28, 2019
5.9K
Olfactomedin 4 in cancer development and progression
Wenli Liu1, Griffin P Rodgers1
1Molecular and Clinical Hematology Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.
Biochimica Et Biophysica Acta. Reviews on Cancer
|August 20, 2025
Summary
Olfactomedin 4 (OLFM4) plays key roles in cell functions and diseases, including cancer. Inhibiting OLFM4 may benefit certain cancers, and it shows potential as an early diagnostic biomarker.
Area of Science:
- Molecular Biology
- Cancer Research
- Immunology
Background:
- Olfactomedin 4 (OLFM4) is an endogenous protein found in human tissues.
- It participates in cellular processes like proliferation, apoptosis, and adhesion.
- OLFM4 is implicated in inflammation, infectious diseases, and various cancers.
Purpose of the Study:
- To investigate the multifaceted roles of OLFM4 in human health and disease.
- To explore OLFM4's context-dependent functions in cancer development and progression.
- To evaluate OLFM4's potential as a therapeutic target and diagnostic biomarker.
Main Methods:
- Analysis of OLFM4 expression patterns in normal and cancerous tissues.
- Investigation of OLFM4's molecular mechanisms in cellular functions.
- Review of existing literature on OLFM4's involvement in disease pathways.
Main Results:
- OLFM4 exhibits context-dependent tumor-suppressing or tumor-promoting effects in different cancers.
- Aberrant OLFM4 expression is observed in multiple human cancers via diverse mechanisms.
- OLFM4's role varies based on tissue and cellular environment.
Conclusions:
- Targeting OLFM4 expression could offer therapeutic benefits in cancers where it promotes tumor growth.
- OLFM4 demonstrates potential as a biomarker for early detection of precancerous conditions.
- Understanding OLFM4's dual role is crucial for developing effective cancer therapies.
More Related Videos
Related Concept Videos
01:25Olfaction
45.1K
The sense of smell is achieved through the activities of the olfactory system. It starts when an airborne odorant enters the nasal cavity and reaches olfactory epithelium (OE). The OE is protected by a thin layer of mucus, which also serves the purpose of dissolving more complex compounds into simpler chemical odorants. The size of the OE and the density of sensory neurons varies among species; in humans, the OE is only about 9-10 cm2.
The olfactory receptors are embedded in the cilia of the...
The olfactory receptors are embedded in the cilia of the...
45.1K
03:03mTOR Signaling and Cancer Progression
3.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.9K
01:03Olfactory Receptors: Location and Structure
9.6K
The process of olfaction, also known as the sense of smell, is a sophisticated chemical response system. The specialized sensory neurons that facilitate this process, known as olfactory receptor neurons, are situated in an upper segment of the nasal cavity, known as the olfactory epithelium. Olfactory sensory neurons are bipolar, with their dendrites extending from the epithelium's apex into the mucus that lines the nasal cavity. Airborne molecules, when inhaled, traverse the olfactory...
9.6K
02:07Tumor Progression
6.5K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.5K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
01:35Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K